![](https://images.advfn.com/static/default-user.png) In the Avila update today:
Aviva Share News - AV. Current Price 408.90p -14.90 -3.52% Bid Price Offer Price 408.80 409.10 High Price Low Price Open Price 418.90 407.50 418.90 Shares Traded Last Trade Market Cap (m) 1,252,824 08:36:14 11,481.77 Aviva PLC Aviva plc Q1 2023 Trading Update Intraday Aviva Chart Intraday Aviva Chart 24/05/2023 7:00am UK Regulatory (RNS & others)
TIDMAV.
RNS Number : 4186A
Aviva PLC
24 May 2023
Page 1
News Release 24 May 2023 Aviva plc Q1 2023 Trading Update
Another quarter of positive delivery. Continued growth momentum across the Group
Strong and resilient capital position. Share buyback nearing completion
On track to meet or exceed Group targets
General Insurance Protection Workplace Retirement Solvency II & Health GBP2.4bn GBP102m GBP1.8bn GBP1.5bn 196% GWP +11% (1) Sales(2) +11% Net flows +25% Sales(2) +17% Shareholder cover ratio Q122 : GBP2.1bn Q122 : GBP92m Q122 : GBP1.4bn Q122 : FY 22 : 212 GBP1.3bn % ------------------- --------------- ----------------- -------------- Amanda Blanc, Group Chief Executive Officer, said:
"We have delivered an encouraging start to 2023 and continue to build clear trading momentum. New business volumes are good, despite persistent economic uncertainty, and we delivered another quarter of strong growth across our diversified business.
"Private healthcare sales grew by 25%, as more individuals and companies are attracted to the benefits of private cover. |
![](https://images.advfn.com/static/default-user.png) Spire Healthcare Group PLC AGM StatementSource: UK Regulatory (RNS & others)TIDMSPIRNS Number : 0236ZSpire Healthcare Group PLC11 May 2023Spire Healthcare Group plc('Spire Healthcare', 'the Group' or 'the Company')AGM STATEMENT11 May 2023Ahead of its Annual General Meeting later today, Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, provides the following update for the period 1 January 2023 to 30 April 2023.The Board is pleased with the Group's performance during the first four months of the year. Consistent with expectations stated in our FY22 results announcement, good momentum has continued from the end of last year. We reiterate our outlook for the full year, as set out in the same announcement.We expect to announce our results for the six months ending 30 June on 14 September 2023.-Ends-For further information please contact: Spire Healthcare +44 (0)20 7427 9000 Angus Prentice - Director of Investor Relations Instinctif Partners +44 (0)20 7457 2020 Damian ReeceGuy ScarboroughRegistered Office and Head Office:Spire Healthcare Group plc3 Dorset RiseLondonEC4Y 8ENRegistered number: 0 9084066About Spire HealthcareSpire Healthcare is a leading independent healthcare group in the United Kingdom, with 39 hospitals and 33 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 700 corporate clients.Working in partnership with over 8,760 experienced consultants, Spire Healthcare delivered tailored, personalised care to approximately 926,500 inpatients, outpatients and day-case patients in 2022, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance (PMI) providers. 98% of Spire Healthcare's inspected hospitals and clinics are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Scotland and Wales.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDAGMSFWEFSEDSESI(END) Dow Jones NewswiresMay 11, 2023 02:00 ET (06:00 GMT) |
Spi AGM on Tuesday might get a positive statement |
On his site yesterday, NT/RB repeated his Spire Target of 235p. He doesn't explain how he chose that value and to me it looks a bit low. Spire is undoubtedly doing very well, hence the share price rise, and there is blue sky on the chart up to around 250p. Unfortunately, the Div is rubbish so my buy is for capital gain only and I'll hang on until the share price appears ready to roll over. pete |
SssshhhhFolks been trading the price range for nearly two years now!. |
Jefferies raises Spire Healthcare to 'buy' (hold) - price target 250 (240) pence |
Must be a big hangover here. 1,000,000 shares bought and the price does not budge |
I hope not! |
SPI could bid for Totally TLY |
Justin Ash CEO of Spire on Ian King, said hangover from Covid meant results were not actually true and the outlook was excellent. More people (middle class) newbies turning to private health, (reason I bought shares) hiring nurses OK yad yadah...
Very optimistic now Covid is in the past. Buying opportunity |
Totally agree. Must be the overall mkt I guess |
See the results which don't look too bad to warrant a drop. |
Any reason for the drop other than profit taking? |
Header from todays Sunday Telegraph article
Nearly half-a-million take out private health insurance in 2022 as NHS crisis deepens
Bupa, Aviva and Vitality, three of the largest UK health insurers, collectively added 480,000 new customers since the beginning of 2022 |
Spire raised to buy at Peel Hunt |
Does anyone know when the next update is please? |
With MDC takeover I wonder how this will affect spi, MDC big shareholder here. |
This is being quite resilient considering wider market |
Slight breakout here looks expensive but slight dividend forecast next year big presentation on spi website |
... from The Sunday Times (Share tip): NHS pain and bid talk boost Spire Healthcare hope.
Not able to read as behind paywall ... |
Big volume again in the pm |
Interesting Well it is a takeover target at these levels |